Improving management of diabetic kidney disease: will GLP-1 receptor agonists have a role?

被引：4
|
作者：
Bellary, Srikanth [1 ,2 ]
Tahrani, Abd A. [2 ,3 ,4 ]
Barnett, Anthony H. [2 ,3 ]
机构：
[1] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England
[2] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England
[3] Univ Birmingham, Inst Metab & Syst Res, Birmingham, W Midlands, England
[4] Birmingham Hlth Partners, Ctr Endocrinol Diabet & Metab CEDAM, Birmingham, W Midlands, England
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2020年 / 8卷 / 11期
关键词：
LIRAGLUTIDE; OUTCOMES;
D O I：
10.1016/S2213-8587(20)30301-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：870 / 871
页数：2
相关论文
共 50 条
  • [31] Positioning on GLP-1 receptor agonists
    Gimenez, Sergio
    Piskorz, Daniel
    Martinez Demaria, Diego
    Nanfara, Silvia
    Lorenzatti, Alberto
    Zapata, Gerardo
    Aguinaga Arrascue, Luis
    Perna, Eduardo
    REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2021, 50 : 4 - 10
  • [32] The Future of the GLP-1 Receptor Agonists
    Hirsch, Irl B.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (15): : 1457 - 1458
  • [33] Emerging role of GLP-1 receptor agonists in the treatment of obesity
    Neff, Lisa M.
    Kushner, Robert F.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2010, 3 : 263 - 273
  • [34] GLP-1 Receptor Agonists in the Treatment of Patients with Type 2 Diabetes and Chronic Kidney Disease
    Neumiller, Joshua J.
    Alicic, Radica Z.
    Tuttle, Katherine R.
    KIDNEY AND DIALYSIS, 2022, 2 (03): : 386 - 398
  • [35] GLP-1 receptor agonists and renal outcomes in patients with diabetes mellitus type 2 and diabetic kidney disease: state of the art
    Granata, Antonio
    Maccarrone, Rosario
    Anzaldi, Massimiliano
    Leonardi, Giuseppe
    Pesce, Francesco
    Amico, Francesco
    Gesualdo, Loreto
    Corrao, Salvatore
    CLINICAL KIDNEY JOURNAL, 2022, 15 (09) : 1657 - 1665
  • [36] Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
    Seghieri, Marta
    Christensen, Alexander S.
    Andersen, Andreas
    Solini, Anna
    Knop, Filip K.
    Vilsboll, Tina
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [37] Do GLP-1 Receptor Agonists Care if You Have Heart Failure?
    Arnott, Clare
    Neal, Bruce
    CIRCULATION, 2019, 140 (20) : 1623 - 1625
  • [38] The Intestines Have a Cardioprotective Role Regulating GLP-1 and GLP-1 Receptor Axis in Hypertensive Cardiomyopathy
    Naruse, Genki
    Kanamori, Hiromitsu
    Iwasa, Masamitsu
    Mikami, Atsushi
    Kawasaki, Masanori
    Nishigaki, Kazuhiko
    Minatoguchi, Shinya
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (09) : S205 - S205
  • [39] Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits-The role of the GLP-1 receptor
    Helmstaedter, Johanna
    Keppeler, Karin
    Kuester, Leonie
    Muenzel, Thomas
    Daiber, Andreas
    Steven, Sebastian
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (04) : 659 - 676
  • [40] Considerations on peri-operative management of GLP-1 receptor agonists
    Mizubuti, Glenio B.
    Nersessian, Rafael S. F.
    da Silva, Leopoldo M.
    Ho, Anthony M. -H.
    ANAESTHESIA, 2025, 80 (03) : 340 - 341
12345